78 results
8-K
EX-1.1
URGN
UroGen Pharma Ltd
18 Jun 24
UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
5:07pm
or governmental charges of whatever nature (other than taxes on net income) imposed or levied by or on behalf of the State of Israel or any political
424B5
URGN
UroGen Pharma Ltd
18 Jun 24
Prospectus supplement for primary offering
5:05pm
that does not distribute all of its earnings on a current basis.
Based on the nature and composition of our income, assets, and activities and our market … use underwriters with whom we have a material relationship. We will describe in the prospectus supplement, naming the underwriter, the nature of any
424B5
URGN
UroGen Pharma Ltd
17 Jun 24
Prospectus supplement for primary offering
4:19pm
from investing in a non-U.S. company that does not distribute all of its earnings on a current basis.
Based on the nature and composition of our income … the underwriter, the nature of any such relationship.
We may sell securities directly or through agents we designate from time to time. We will name any agent
8-K
EX-99.1
5ia6m5q
4 Mar 24
Regulation FD Disclosure
7:00am
8-K
EX-99.1
f92v8g m51oa5g1dnc
7 Feb 24
Regulation FD Disclosure
4:15pm
CORRESP
5qfpexbnsbbd0lod5cj
27 Nov 23
Correspondence with SEC
12:00am
UPLOAD
5lcmhbzx6ia6jdanpa
16 Nov 23
Letter from SEC
12:00am
D
dqbrq o2dm4
14 Aug 23
$120.00 mm in equity / options / securities to be acquired, sold $120.00 mm, 8 investors
2:06pm